Sanofi Signs Trio of Deals to Bolster Diabetes and Oncology Pipelines
By Heather Cartwright & Rohit Khera
Pharma Deals Review: Vol 2015 Issue 12 (Table of Contents)
Published: 2 Dec-2015
DOI: 10.3833/pdr.v2015.i12.2133 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In the first of three deals announced in the space of a week, Sanofi has partnered with German biotech BioNTech to discover and develop up to five mRNA-based cancer immunotherapies in deal potentially worth up to US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS